Role of secretin peptide family and their receptors in the hypothalamic control of energy homeostasis

Hormone and Metabolic Research

Volumn 45, Issue 13, 2013, Pages 945-954

  Sekar, R ^a   Chow, B K C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

energy homeostasis; food intake; hypothalamus; secretin family peptides; secretin family receptors

Indexed keywords

ADENYLATE CYCLASE; ADRENOMEDULLIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN RELEASING FACTOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GROWTH HORMONE RELEASING FACTOR; INTERMEDIN; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

CHOLINERGIC SYSTEM; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INSULIN RELEASE; LASER CAPTURE MICRODISSECTION; NODOSE GANGLION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; THERMOGENESIS; WILD TYPE;

ANIMALS; ENERGY METABOLISM; HUMANS; HYPOTHALAMUS; RECEPTORS, G-PROTEIN-COUPLED; SECRETIN;

EID: 84890551171     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1353155     Document Type: Review

References (192)

1. Cardoso J. C., Vieira F. A., Gomes A. S., Power D. M. The serendipitous origin of chordate secretin peptide family members. BMC Evol Biol: 2010; 10 135
2. Lee VH Y., Lee LT O., Chu JY S., Lam IP Y., Siu FK Y., Vaudry H., Chow BK C. An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II. FASEB J: 2010; 24 5024 5032
3. Borle A. B. Regulation of cellular calcium metabolism and calcium transport by calcitonin. J Membr Biol: 1975; 21 125 146
4. Laburthe M., Couvineau A., Gaudin P., Maorett J. J., Rouyer-Fessard C., Nicole P. Receptors for VIP, PACAP, Secretin, GRF, Glucagon, GLP-1, and Other Members of Their New Family of G Protein-Linked Receptors: Structure-Function Relationship with Special Reference to the Human VIP-1 Receptora. Ann N Y Acad Sci: 1996; 805 94 109
5. Harmar A. J. Family-B G-protein-coupled receptors. Genome Biol: 2001; 2 reviews 3013.1 reviews 3013.10
6. Archbold J. K., Flanagan J. U., Watkins H. A., Gingell J. J., Hay D. L. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends Pharmacol Sci: 2011; 32 591 600
7. Watkins H. A., Au M., Hay D. L. The structure of secretin family GPCR peptide ligands: implications for receptor pharmacology and drug development. Drug Discov Today: 2012; 17-18 1006 1014 Erratum in Drug Discov Today 2013; 18: 312-313
8. Poyner D. R., Hay D. L. Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives. Br J Pharmacol: 2012; 166 1 3
9. Furness S. G., Wootten D., Christopoulos A., Sexton P. M. Consequences of splice variation on Secretin family G protein-coupled receptor function. Br J Pharmacol: 2012; 166 98 109
10. de Lecea L., Kilduff T., Peyron C., Gao X-B, Foye P., Danielson P., Fukuhara C., Battenberg E., Gautvik V., Bartlett F. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA: 1998; 95 322 327 (Pubitemid 28103952)
11. Dogrukol-Ak D., Tore F., Tuncel N. Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects. Curr Pharm Des: 2004; 10 1325 1340 (Pubitemid 38559750)
12. Williams G., Bing C., Cai X. J., Harrold J. A., King P. J., Liu X. H. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav: 2001; 74 683
13. Leibowitz S. F., Wortley K. E. Hypothalamic control of energy balance: different peptides, different functions. Peptides: 2004; 25 473 504 (Pubitemid 38591557)
14. Dietrich M. O., Horvath T. L. Hypothalamic control of energy balance: insights into the role of synaptic plasticity. Trends Neurosci: 2013; 36 65 73
15. Morton G., Cummings D., Baskin D., Barsh G., Schwartz M. Central nervous system control of food intake and body weight. Nature: 2006; 443 289 295 (Pubitemid 44435142)
16. Grill H. J., Kaplan J. M. The neuroanatomical axis for control of energy balance. Front Neuroendocrinol: 2002; 23 2 40 (Pubitemid 34121907)
17. Lopaschuk G. D., Ussher J. R., Jaswal J. S. Targeting Intermediary Metabolism in the Hypothalamus as a Mechanism to Regulate Appetite. Pharmacol Rev: 2010; 62 237 264
18. Thorens B. Sensing of glucose in the brain. In: Appetite Control. Joost H-G. (ed.). Springer: Handbook of Experimental Pharmacology: 2012; 209 277 294
19. Burdakov D., Luckman S. M., Verkhratsky A. Glucose-sensing neurons of the hypothalamus. Philos Trans R Soc Lond B Biol Sci: 2005; 360 2227 2235 (Pubitemid 46682141)
20. Parton L. E., Ye C. P., Coppari R., Enriori P. J., Choi B., Zhang C-Y, Xu C., Vianna C. R., Balthasar N., Lee C. E. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature: 2007; 449 228 232 (Pubitemid 47402365)
21. Mounien L., Marty N., Tarussio D., Metref S., Genoux D., Preitner F., Foretz M., Thorens B. Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons. FASEB J: 2010; 24 1747 1758
22. Lam C. K., Chari M., Lam T. K. CNS regulation of glucose homeostasis. Physiology: 2009; 24 159 170
23. Bayliss W. M., Starling E. H. The mechanism of pancreatic secretion. J Physiol: 1902; 28 325 353
24. Lam IP Y., Siu FK Y., Chu JY S., Chow BK C. Multiple Actions of Secretin in the Human Body. In: International Review of Cytology. Kwang W. J. (ed.). New York Academic Press: 2008; 159 190 (Pubitemid 351215988)
25. Chey W. Y., Chang T-M. Secretin, 100 years later. J Gastroenterol: 2003; 38 1025 1035 (Pubitemid 38016361)
26. Ng S. S., Yung W., Chow B. K. Secretin as a neuropeptide. Mol Neurobiol: 2002; 26 97 107 (Pubitemid 35176870)
27. Chu JY S., Lee LT O., Lai C. H., Vaudry H., Chan Y. S., Yung W. H., Chow BK C. Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci USA: 2009; 106 15961 15966
28. Chu J., Yung W., Chow B. Secretin: a pleiotrophic hormone. Ann N Y Acad Sci: 2006; 1070 27 50 (Pubitemid 44126624)
29. O'Donohue T. L., Charlton C. G., Miller R. L., Boden G., Jacobowitz D. M. Identification, characterization, and distribution of secretin immunoreactivity in rat and pig brain. Proc Natl Acad Sci USA: 1981; 78 5221 5224 (Pubitemid 12229706)
30. Samson W. K., Lumpkin M. D., McCann S. M. Presence and possible site of action of secretin in the rat pituitary and hypothalamus. Life Sci: 1984; 34 155 163 (Pubitemid 14214735)
31. Charlton C. G., O'Donohue T. L., Miller R. L., Jacobowitz D. M. Secretin immunoreactivity in rat and pig brain. Peptides: 1981; 2 01 45 49 (Pubitemid 12232320)
32. Welch M. G., Keune J. D., Welch-Horan T. B., Anwar N., Anwar M., Ludwig R. J., Ruggiero D. A. Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism. Cell Mol Neurobiol: 2004; 24 219 241 (Pubitemid 38481019)
33. Tay J., Goulet M., Rusche J., Boismenu R. Age-related and regional differences in secretin and secretin receptor mRNA levels in the rat brain. Neurosci Lett: 2004; 366 176 181 (Pubitemid 38970151)
34. Cheng CY Y., Chu JY S., Chow BK C. Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System. Neuropsychopharmacology: 2011; 36 459 471
35. Glick Z., Thomas D. W., Mayer J. Absence of effect of injections of the intestinal hormones secretin and cholecystokinin-pancreozymin upon feeding behavior. Physiol Behav: 1971; 6 5 8
36. Gibbs J., Young R. C., Smith G. P. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol: 1973; 84 488 495
37. Lorenz D. N., Kreielsheimer G., Smith G. P. Effect of cholecystokinin, gastrin, secretin and GIP on sham feeding in the rat. Physiol Behav: 1979; 23 1065 1072 (Pubitemid 10104546)
38. Yang H., Wang L., Wu S. V., Tay J., Goulet M., Boismenu R., Czimmer J., Wang Y., Wu S., Ao Y., Taché Y. Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent. Neuroscience: 2004; 128 131 141 (Pubitemid 39140686)
39. Chu J. Y., Cheng C. Y., Sekar R., Chow B. K. Vagal Afferent Mediates the Anorectic Effect of Peripheral Secretin. PloS One: 2013; 8 e64859
40. Banks W. A., Goulet M., Rusche J. R., Niehoff M. L., Boismenu R. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse. J Pharmacol Exp Therap: 2002; 302 1062 1069 (Pubitemid 34920227)
41. Li Y., Wu X., Yao H., Owyang C. Secretin activates vagal primary afferent neurons in the rat: evidence from electrophysiological and immunohistochemical studies. Am J Physiol Gastrointest Liver Physiol: 2005; 289 G745 G752 (Pubitemid 41377182)
42. Sekar R., Chow BK C. Metabolic effects of secretin. Gen Comp Endocrinol: 2013; 181 18 24
43. Chu J. Y., Yung W. H., Chow B. K. Endogenous release of secretin from the hypothalamus. Ann N Y Acad Sci: 2006; 1070 196 200 (Pubitemid 44126641)
44. Heppner K. M., Habegger K. M., Day J., Pfluger P. T., Perez-Tilve D., Ward B., Gelfanov V., Woods S. C., DiMarchi R., Tschöp M. Glucagon regulation of energy metabolism. Physiol Behav: 2010; 100 545 548
45. Habegger K. M., Heppner K. M., Geary N., Bartness T. J., DiMarchi R., Tschop M. H. The metabolic actions of glucagon revisited. Nat Rev Endocrinol: 2010; 6 689 697
46. Jones B. J., Tan T., Bloom S. R. Minireview: Glucagon in Stress and Energy Homeostasis. Endocrinology: 2012; 153 1049 1054
47. Penick S. B., Hinkle L. E. Jr. Depression of food intake induced in healthy subjects by glucagon. N Engl J Med: 1961; 264 893 897
48. Martin J. R., Novin D. Decreased feeding in rats following hepatic-portal infusion of glucagon. Physiol Behav: 1977; 19 461 466 (Pubitemid 8317175)
49. Geary N., Kissileff H. R., Pi-Sunyer F. X., Hinton V. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol Regul Integ Comp Physiol: 1992; 262 R975 R980
50. Geary N., Smith G. P. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiol Behav: 1983; 31 391 394
51. Morawska D., Sieklucka-Dziuba M., Kleinrok Z. Central action of glucagon. Pol J Pharmacol: 1998; 50 125 133 (Pubitemid 28253197)
52. Honda K., Kamisoyama H., Uemura T., Yanagi T., Saito N., Kurose Y., Sugahara K., Katoh K., Hasegawa S. The mechanism underlying the central glucagon-induced hyperglycemia and anorexia in chicks. Comp Biochem Physiol A Mol Integ Physiol: 2012; 163 260 264
53. Kurose Y., Kamisoyama H., Honda K., Azuma Y., Sugahara K., Hasegawa S., Kobayashi S. Effects of central administration of glucagon on feed intake and endocrine responses in sheep. Anim Sci J: 2009; 80 686 690
54. Shimizu H., Egawa M., Yoshimatsu H., Bray G. A. Glucagon injected in the lateral hypothalamus stimulates sympathetic activity and suppresses monoamine metabolism. Brain Res: 1993; 630 95 100 (Pubitemid 23342831)
55. Inokuchi A., Oomura Y., Shimizu N., Yamamoto T. Central action of glucagon in rat hypothalamus. Am J Physiol Regul Integ Comp Physiol: 1986; 250 R120 R126
56. Hoosein N. M., Gurd R. S. Identification of glucagon receptors in rat brain. Proc Natl Acad Sci: 1984; 81 4368 4372 (Pubitemid 14052446)
57. Parker J. A., McCullough K. A., Field B. C., Minnion J. S., Martin N. M., Ghatei M. A., Bloom S. R. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int J Obes (Lond): 2013; 10.1038/ijo.2012.227 [Epub ahead of print]
58. Baggio L. L., Drucker D. J. Biology of incretins: GLP-1 and GIP. Gastroenterology: 2007; 132 2131 2157 (Pubitemid 46711096)
59. Holst J. J. The physiology of glucagon-like peptide 1. Physiol Rev: 2007; 87 1409 1439 (Pubitemid 350041474)
60. Kreymann B., Ghatei M., Williams G., Bloom S. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet: 1987; 330 1300 1304 (Pubitemid 17156636)
61. Barrera J. G., Sandoval D. A., D'Alessio D. A., Seeley R. J. GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat Rev Endocrinol: 2011; 7 507 516
62. Hayes M. R. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects. Physiol Behav: 2012; 106 413 416
63. Hayes M. R., De Jonghe B. C., Kanoski S. E. Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav: 2010; 100 503 510
64. Meier J. J., Gallwitz B., Schmidt W. E., Nauck M. A. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol: 2002; 440 269 279 (Pubitemid 34460704)
65. Punjabi M., Arnold M., Geary N., Langhans W., Pacheco-López G. Peripheral glucagon-like peptide-1 (GLP-1) and satiation. Physiol Behav: 2011; 105 71 76
66. Hayes M. R., Kanoski S. E., De Jonghe B. C., Leichner T. M., Alhadeff A. L., Fortin S. M., Arnold M., Langhans W., Grill H. J. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am J Physiol Regul Integ Comp Physiol: 2011; 301 R1479 R1485
67. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol Endocrinol Metabol: 1996; 271 E808 E813
68. Hayes M. R., Bradley L., Grill H. J. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology: 2009; 150 2654 2659
69. Kanoski S. E., Fortin S. M., Arnold M., Grill H. J., Hayes M. R. Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4. Endocrinology: 2011; 152 3103 3112
70. Turton M., O'shea D., Gunn I., Beak S., Edwards C., Meeran K., Choi S., Taylor G., Heath M., Lambert P. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature: 1996; 379 69 72 (Pubitemid 26008136)
71. Knauf C., Cani P. D., Perrin C., Iglesias M. A., Maury J. F., Bernard E., Benhamed F., Grémeaux T., Drucker D. J., Kahn C. R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest: 2005; 115 3554 3563 (Pubitemid 43121843)
72. Williams D. L. Minireview: Finding the Sweet Spot: Peripheral Versus Central Glucagon-Like Peptide 1 Action in Feeding and Glucose Homeostasis. Endocrinology: 2009; 150 2997 3001
73. Sandoval D. A., Bagnol D., Woods S. C., D'Alessio D. A., Seeley R. J. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes: 2008; 57 2046 2054
74. Tang-Christensen M., Larsen P., Goke R., Fink-Jensen A., Jessop D., Moller M., Sheikh S. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol Regul Integ Comp Physiol: 1996; 271 R848 R856
75. Thiele T. E., Van Dijk G., Campfield L. A., Smith F. J., Burn P., Woods S. C., Bernstein I. L., Seeley R. J. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol Regul Integ Comp Physiol: 1997; 272 R726 R730
76. McMahon L. R., Wellman P. J. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol Regul Integ Comp Physiol: 1998; 274 R23 R29
77. Kinzig K. P., D'Alessio D. A., Seeley R. J. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci: 2002; 22 10470 10476 (Pubitemid 35416883)
78. Kinzig K. P., D'Alessio D. A., Herman J. P., Sakai R. R., Vahl T. P., Figueiredo H. F., Murphy E. K., Seeley R. J. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J Neurosci: 2003; 23 6163 6170 (Pubitemid 36875615)
79. Challa T. D., Beaton N., Arnold M., Rudofsky G., Langhans W., Wolfrum C. Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol Chem: 2012; 287 6421 6430
80. Hayes M. R., Skibicka K. P., Grill H. J. Caudal Brainstem Processing Is Sufficient for Behavioral, Sympathetic, and Parasympathetic Responses Driven by Peripheral and Hindbrain Glucagon-Like-Peptide-1 Receptor Stimulation. Endocrinology: 2008; 149 4059 4068
81. Alhadeff A. L., Rupprecht L. E., Hayes M. R. GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake. Endocrinology: 2012; 153 647 658
82. Dossat A. M., Lilly N., Kay K., Williams D. L. Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake. J Neurosci: 2011; 31 14453 14457
83. Goldstone A. P., Mercer J. G., Gunn I., Moar K. M., Edwards CM B., Rossi M., Howard J. K., Rasheed S., Turton M. D., Small C. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett: 1997; 415 134 138 (Pubitemid 27430055)
84. Scrocchi L. A., Drucker D. J. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor-/- mice. Endocrinology: 1998; 139 3127 3132 (Pubitemid 28512341)
85. Buse J. B., Rosenstock J., Sesti G., Schmidt W. E., Montanya E., Brett J. H., Zychma M., Blonde L. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet: 2009; 374 39 47
86. Buse J. B., Henry R. R., Han J., Kim D. D., Fineman M. S., Baron A. D. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care: 2004; 27 2628 2635 (Pubitemid 39441462)
87. Kendall D. M., Riddle M. C., Rosenstock J., Zhuang D., Kim D. D., Fineman M. S., Baron A. D. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care: 2005; 28 1083 1091 (Pubitemid 40616617)
88. Astrup A., Rössner S., Van Gaal L., Rissanen A., Niskanen L., Al Hakim M., Madsen J., Rasmussen M. F., Lean M. E. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet: 2009; 374 1606 1616
89. Morínigo R., Lacy A. M. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg: 2006; 16 1594 1601 (Pubitemid 46032812)
90. Emeric-Sauval E. Corticotropin-releasing factor (CRF) - a review. Psychoneuroendocrinology: 1986; 11 277 294 (Pubitemid 16002251)
91. Rivier C. L., Plotsky P. M. Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Ann Rev Physiol: 1986; 48 475 494 (Pubitemid 16047629)
92. Liposits Z., Phelix C., Paull W. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry: 1987; 86 541 549 (Pubitemid 17076448)
93. Dunn A. J., Berridge C. W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses. Brain Res Rev: 1990; 15 100
94. Turnbull A. V., Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. In: Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. New York, NY Royal Society of Medicine: 1997; 1 10
95. Rothwell N. J. Central effects of CRF on metabolism and energy balance. Neurosci Biobehav Rev: 1990; 14 263 271 (Pubitemid 20266408)
96. Owens M. J., Nemeroff C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev: 1991; 43 425 473
97. Tanaka C., Asakawa A., Ushikai M., Sakoguchi T., Amitani H., Terashi M., Cheng K., Chaolu H., Nakamura N., Inui A. Comparison of the anorexigenic activity of CRF family peptides. Biochem Biophy Res Commun: 2009; 390 887 891
98. Richard D., Lin Q., Timofeeva E. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur J Pharmacol: 2002; 440 189 197 (Pubitemid 34458023)
99. Smith G. W., Aubry J-M, Dellu F., Contarino A., Bilezikjian L. M., Gold L. H., Chen R., Marchuk Y., Hauser C., Bentley C. A., Sawchenko P. E., Koob G. F., Vale W., Lee K-F. Corticotropin Releasing Factor Receptor 1-Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development. Neuron: 1998; 20 1093 1102 (Pubitemid 28293127)
100. Doyon C., Samson P., Lalonde J., Richard D. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats. J Endocrinol: 2007; 193 11 19 (Pubitemid 46638527)
101. Chao H., Digruccio M., Chen P., Li C. Type 2 Corticotropin-Releasing Factor Receptor in the Ventromedial Nucleus of Hypothalamus Is Critical in Regulating Feeding and Lipid Metabolism in White Adipose Tissue. Endocrinology: 2012; 153 166 176
102. Chen P., Van Hover C., Lindberg D., Li C. Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus. Front Endocrinol (Lausanne): 2012; 3 180, 10.3389/fendo.2012.00180 [Epub 2013 Jan 7]
103. Carlin K. M., Vale W. W., Bale T. L. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc Natl Acad Sci USA: 2006; 103 3462 3467 (Pubitemid 43346491)
104. Bradbury M. J., McBurnie M. I., Denton D. A., Lee K-F, Vale W. W. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology: 2000; 141 2715 2724 (Pubitemid 32250431)
105. Coste S. C., Kesterson R. A., Heldwein K. A., Stevens S. L., Heard A. D., Hollis J. H., Murray S. E., Hill J. K., Pantely G. A., Hohimer A. R. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Gen: 2000; 24 403 409 (Pubitemid 30187442)
106. Lu X-Y, Barsh G. S., Akil H., Watson S. J. Interaction between α-Melanocyte-Stimulating Hormone and Corticotropin-Releasing Hormone in the Regulation of Feeding and Hypothalamo-Pituitary-Adrenal Responses. J Neurosci: 2003; 23 7863 7872 (Pubitemid 37052354)
107. Kawashima S., Sakihara S., Kageyama K., Nigawara T., Suda T. Corticotropin-releasing factor (CRF) is involved in the acute anorexic effect of a-melanocyte-stimulating hormone: A study using CRF-deficient mice. Peptides: 2008; 29 2169 2174 (Pubitemid 50315792)
108. Heilig M., Koob G. F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci: 2007; 30 399 406 (Pubitemid 47090230)
109. Bogdan R., Santesso D. L., Fagerness J., Perlis R. H., Pizzagalli D. A. Corticotropin-releasing hormone receptor type 1 (CRHR1) genetic variation and stress interact to influence reward learning. J Neurosci: 2011; 31 13246 13254
110. Cottone P., Sabino V., Roberto M., Bajo M., Pockros L., Frihauf J. B., Fekete E. M., Steardo L., Rice K. C., Grigoriadis D. E. CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci USA: 2009; 106 20016 20020
111. Miyata A., Arimura A., Dahl R. R., Minamino N., Uehara A., Jiang L., Culler M. D., Coy D. H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun: 1989; 164 567 574 (Pubitemid 19269770)
112. Vaudry D., Gonzalez B. J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions. Pharmacol Rev: 2000; 52 269 324 (Pubitemid 30368434)
113. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow BK C., Hashimoto H., Galas L., Vaudry H. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery. Pharmacol Rev: 2009; 61 283 357
114. Koves K., Arimura A., Gorcs T. G., Somogyvari-Vigh A. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology: 1991; 54 159 169
115. Morley J. E., Horowitz M., Morley P. M., Flood J. F. Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice. Peptides: 1992; 13 1133 1135 (Pubitemid 23010907)
116. Dürr K., Norsted E., Gömüç B., Suarez E., Hannibal J., Meister B. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) defines a subpopulation of hypothalamic POMC neurons. Brain Res: 2007; 1186 203 211
117. Mounien L., Bizet P., Boutelet I., Gourcerol G., Fournier A., Vaudry H., Jégou S. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience: 2006; 143 155 163 (Pubitemid 44755235)
118. Mounien L., Bizet P., Boutelet I., Gourcerol G., Basille M., Gonzalez B., Vaudry H., Jegou S. Expression of PACAP Receptor mRNAs by Neuropeptide Y Neurons in the Rat Arcuate Nucleus. Ann N Y Acad Sci: 2006; 1070 457 461 (Pubitemid 44126686)
119. Nakata M., Kohno D., Shintani N., Nemoto Y., Hashimoto H., Baba A., Yada T. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neurosci Lett: 2004; 370 252 256 (Pubitemid 39370889)
120. Mounien L., Do Rego J. C., Bizet P., Boutelet I., Gourcerol G., Fournier A., Brabet P., Costentin J., Vaudry H., Jegou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology: 2009; 34 424 435
121. Resch J. M., Boisvert J. P., Hourigan A. E., Mueller C. R., Yi S. S., Choi S. Stimulation of the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating polypeptide induces hypophagia and thermogenesis. Am J Physiol Regul Integ Comp Physiol: 2011; 301 R1625 R1634
122. Hawke Z., Ivanov T. R., Bechtold D. A., Dhillon H., Lowell B. B., Luckman S. M. PACAP Neurons in the Hypothalamic Ventromedial Nucleus Are Targets of Central Leptin Signaling. J Neurosci: 2009; 29 14828 14835
123. Adams B. A., Gray S. L., Isaac E. R., Bianco A. C., Vidal-Puig A. J., Sherwood N. M. Feeding and Metabolism in Mice Lacking Pituitary Adenylate Cyclase-Activating Polypeptide. Endocrinology: 2008; 149 1571 1580 (Pubitemid 351468343)
124. Sherwood N. M., Adams B. A., Isaac E. R., Wu S., Fradinger E. A. Knocked down and out: PACAP in development, reproduction and feeding. Peptides: 2007; 28 1680 1687 (Pubitemid 47361410)
125. Yi C-X, Sun N., Ackermans M. T., Alkemade A., Foppen E., Shi J., Serlie M. J., Buijs R. M., Fliers E., Kalsbeek A. Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Glucose Production via the Hepatic Sympathetic Innervation in Rats. Diabetes: 2010; 59 1591 1600
126. Said S. I., Mutt V. Isolation from Porcine-Intestinal Wall of a Vasoactive Octacosapeptide Related to Secretin and to Glucagon. Eur J Biochem: 1972; 28 199 204
127. Fuxe K., Hökfelt T., Said S. I., Mutt V. Vasoactive intestinal polypeptide and the nervous system: Immunohistochemical evidence for localization in central and peripheral neurons, particularly intracortical neurons of the cerebral cortex. Neurosci Lett: 1977; 5 241 246 (Pubitemid 8157644)
128. Dussaillant M., Sarrieau A., Gozes I., Berod A., Rostene W. Distribution of cells expressing vasoactive intestinal peptide/peptide histidine isoleucine-amide precursor messenger rna in the rat brain. Neuroscience: 1992; 50 519 530
129. Usdin T. B., Bonner T. I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology: 1994; 135 2662 2680 (Pubitemid 24377430)
130. Alexander L. D., Sander L. D. Vasoactive intestinal peptide stimulates ACTH and corticosterone release after injection into the PVN. Regul Pept: 1994; 51 221 227 (Pubitemid 24197398)
131. Alexander L. D., Sander L. D. Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone. Neuropeptides: 1995; 28 167 173
132. Tachibana T., Saito S., Tomonaga S., Takagi T., Saito E-S, Boswell T., Furuse M. Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks. Neurosci Lett: 2003; 339 203 206 (Pubitemid 36299001)
133. Matsuda K., Maruyama K., Nakamachi T., Miura T., Uchiyama M., Shioda S. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus. Peptides: 2005; 26 1611 1616 (Pubitemid 41169755)
134. Ghourab S., Beale K. E., Semjonous N. M., Simpson K. A., Martin N. M., Ghatei M. A., Bloom S. R., Smith K. L. Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake. Regul Pept: 2011; 172 8 15
135. Jozsa R., Nemeth J., Tamas A., Hollosy T., Lubics A., Jakab B., Olah A., Lengvari I., Arimura A., Reglödi D. Short-Term Fasting Differentially Alters PACAP and VIP Levels in the Brains of Rat and Chicken. Ann N Y Acad Sci: 2006; 1070 354 358 (Pubitemid 44126668)
136. Bechtold D. A., Brown T. M., Luckman S. M., Piggins H. D. Metabolic rhythm abnormalities in mice lacking VIP-VPAC2 signaling. Am J Physiol Regul Integ Comp Physiol: 2008; 294 R344 R351 (Pubitemid 351213737)
137. Alexander L. D., Evans K., Sander L. D. A possible involvement of VIP in feeding-induced secretion of ACTH and corticosterone in the Rat. Physiol Behav: 1995; 58 409 413
138. Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W. B., Guillemin R. Growth hormone-releasing factor from ovine and caprine hypothalamus: Isolation, sequence analysis and total synthesis. Biochem Biophys Res Commun: 1984; 125 606 614 (Pubitemid 15155740)
139. Krulich L., Dhariwal AP S., Mccann S. M. Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitary in Vitro. Endocrinology: 1968; 83 783 790
140. Esch F., Böhlen P., Ling N., Brazeau P., Guillemin R. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun: 1983; 117 772 779 (Pubitemid 14185039)
141. VandePol C. J., Leidy J. W. Jr, Finger T. E., Robbins R. J. Immunohistochemical localization of GRF-containing neurons in rat brain. Neuroendocrinology: 1986; 42 143 147 (Pubitemid 16185693)
142. Vaccarino F. J., Feifel D., Rivier J., Vale W., Koob G. F. Centrally administered hypothalamic growth hormone-releasing factor stimulates food intake in free-feeding rats. Peptides: 1988; 9 01 35 38
143. Vaccarino F. J., Bloom F. E., Rivier J., Vale W., Koob G. F. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature: 1985; 314 167 168 (Pubitemid 15137125)
144. Sawchenko P. E., Swanson L. W., Rivier J., Vale W. W. The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol: 1985; 237 100 115 (Pubitemid 15040610)
145. Vaccarino F. J., Hayward M. Microinjections of growth hormone-releasing factor into the medial preoptic area/suprachiasmatic nucleus region of the hypothalamus stimulate food intake in rats. Regul Pept: 1988; 21 21 28
146. Dickson P. R., Vaccarino F. J. Characterization of feeding behavior induced by central injection of GRF. Am J Physiol Regul Integ Comp Physiol: 1990; 259 R651 R657 (Pubitemid 20307591)
147. Dickson P. R., Vaccarino F. J. GRF-induced feeding: Evidence for protein selectivity and opiate involvement. Peptides: 1994; 15 1343 1352
148. Vaccarino F. J., Buckenham K. E. Naloxone blockade of growth hormone-releasing factor-induced feeding. Regul Pept: 1987; 18 165 171 (Pubitemid 17138589)
149. Vaccarino F. J., Taube M. R. Intra-Arcuate Opiate Actions Stimulate GRF-Dependent and Protein-Selective Feeding. Peptides: 1997; 18 197 205 (Pubitemid 27224384)
150. Rusak B., Zucker I. Neural regulation of circadian rhythms. Physiol Rev: 1979; 59 449 526 (Pubitemid 9236598)
151. Feifel D., Vaccarino F. J. Feeding effects of growth hormone-releasing factor in rats are photoperiod sensitive. Behav Neurosci: 1989; 103 824 830 (Pubitemid 19218414)
152. Vaccarino F., Feifel D., Rivier J., Vale W. Antagonism of central growth hormone-releasing factor activity selectively attenuates dark-onset feeding in rats. J Neurosci: 1991; 11 3924 3927
153. Dickson P. R., Feifel D., Vaccarino F. J. Blockade of endogenous GRF at dark onset selectively suppresses protein intake. Peptides: 1995; 16 7 9
154. Feifel D., Vaccarino F. J. Growth hormone-regulatory peptides (GHRH and somatostatin) and feeding: A model for the integration of central and peripheral function. Neurosci Biobehav Rev: 1994; 18 421 433 (Pubitemid 24258714)
155. Roh J., Chang C. L., Bhalla A., Klein C., Hsu SY T. Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes. J Biol Chem: 2004; 279 7264 7274 (Pubitemid 38248876)
156. Poyner D. R., Sexton P. M., Marshall I., Smith D. M., Quirion R., Born W., Muff R., Fischer J. A., Foord S. M. International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors. Pharmacol Rev: 2002; 54 233 246 (Pubitemid 34575714)
157. Lutz T. A., Rossi R., Althaus J., Del Prete E., Scharrer E. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides: 1998; 19 1533 1540 (Pubitemid 29015894)
158. Flynn J. J., Margules D. L., Cooper C. W. Presence of immunoreactive calcitonin in the hypothalamus and pituitary lobes of rats. Brain Res Bull: 1981; 6 547 549 (Pubitemid 11045712)
159. Yamamoto Y., Nakamuta H., Koida M., Seyler J. K., Orlowski R. C. Calcitonin-induced anorexia in rats: a structure-activity study by intraventricular injections. Jap J Pharmacol: 1982; 32 1013
160. Perlow M. J., Freed W. J., Carman J. S., Wyatt R. J. Calcitonin reduces feeding in man, monkey and rat. Pharmacol Biochem Behav: 1980; 12 609 612 (Pubitemid 10070131)
161. Gaggi R., Beltrandi E., Dall'Olio R., Ferri S. Relationships between hypocalcaemic and anorectic effect of calcitonin in the rat. Pharmacol Res Commun: 1985; 17 209 215 (Pubitemid 15056524)
162. de Beaurepaire R., Freed W. J. Anatomical mapping of the rat hypothalamus for calcitonin-induced anorexia. Pharmacol Biochem Behav: 1987; 27 177 182 (Pubitemid 17096857)
163. Chelikani P. K., Haver A. C., Reidelberger R. D. Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats. Am J Physiol Regul Integ Comp Physiol: 2007; 293 R1798 R1808 (Pubitemid 350085656)
164. Morley J. E., Levine A. S., Brown D. M., Handwerger B. S. The effect of calcitonin on food intake in diabetic mice. Peptides: 1982; 3 17 20 (Pubitemid 12077844)
165. Eiden S., Daniel C., Steinbrueck A., Schmidt I., Simon E. Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents. J Physiol: 2002; 541 1041 1048 (Pubitemid 35190261)
166. Bello N. T., Kemm M. H., Moran T. H. Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys. Am J Physiol Regul Integ Comp Physiol: 2008; 295 R76 R81
167. Zhang Z., Liu X., Morgan D. A., Kuburas A., Thedens D. R., Russo A. F., Rahmouni K. Neuronal Receptor Activity-Modifying Protein 1 Promotes Energy Expenditure in Mice. Diabetes: 2011; 60 1063 1071
168. Dhillo W. S., Small C. J., Jethwa P. H., Russell S. H., Gardiner J. V., Bewick G. A., Seth A., Murphy K. G., Ghatei M. A., Bloom S. R. Paraventricular Nucleus Administration of Calcitonin Gene-Related Peptide Inhibits Food Intake and Stimulates the Hypothalamo-Pituitary-Adrenal Axis. Endocrinology: 2003; 144 1420 1425 (Pubitemid 36428484)
169. Sun J. Y., Jing M. Y., Wang J. F., Weng X. Y. Original Article: The approach to the mechanism of calcitonin gene-related peptide-inducing inhibition of food intake. J Anim Physiol Anim Nutr: 2010; 94 552 560
170. Taylor G. M., Meeran K., O'Shea D., Smith D. M., Ghatei M. A., Bloom S. R. Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors. Endocrinology: 1996; 137 3260 3264 (Pubitemid 26250172)
171. Taylor M. M., Bagley S. L., Samson W. K. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol Regul Integ Comp Physiol: 2005; 288 R919 R927 (Pubitemid 40404167)
172. Sawada H., Yamaguchi H., Shimbara T., Toshinai K., Mondal M. S., Date Y., Murakami N., Katafuchi T., Minamino N., Nunoi H., Nakazato M. Central Effects of Calcitonin Receptor-Stimulating Peptide-1 on Energy Homeostasis in Rats. Endocrinology: 2006; 147 2043 2050
173. Lutz T. A. Amylinergic control of food intake. Physiol Behav: 2006; 89 465 471 (Pubitemid 44634569)
174. Rushing P. A. Central amylin signaling and the regulation of energy homeostasis. Curr Pharmaceut Des: 2003; 9 819 825 (Pubitemid 36367604)
175. Lutz T. A. The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integ Comp Physiol: 2010; 298 R1475 R1484
176. Lutz T. Control of energy homeostasis by amylin. Cell Mol Life Sci: 2012; 69 1947 1965
177. Woods S. C., Lutz T. A., Geary N., Langhans W. Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci: 2006; 361 1219 1235 (Pubitemid 44882937)
178. Roth J. D., Roland B. L., Cole R. L., Trevaskis J. L., Weyer C., Koda J. E., Anderson C. M., Parkes D. G., Baron A. D. Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA: 2008; 105 7257 7262 (Pubitemid 351754465)
179. Turek V. F., Trevaskis J. L., Levin B. E., Dunn-Meynell A. A., Irani B., Gu G., Wittmer C., Griffin P. S., Vu C., Parkes D. G. Mechanisms of amylin/leptin synergy in rodent models. Endocrinology: 2010; 151 143 152
180. Mack C., Soares C., Wilson J., Athanacio J., Turek V., Trevaskis J., Roth J., Smith P., Gedulin B., Jodka C. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight. Inter J Obes: 2009; 34 385 395
181. Guan X., Shi X., Li X., Chang B., Wang Y., Li D-P, Chan L. GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility. Am J Physiol Endocrinol Metab: 2012; 303 E853 E864
182. Tang-Christensen M., Larsen P. J., Thulesen J., Romer J., Vrang N. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med: 2000; 6 802 807 (Pubitemid 30469430)
183. Dalvi P. S., Belsham D. D. Glucagon-Like Peptide-2 Directly Regulates Hypothalamic Neurons Expressing Neuropeptides Linked to Appetite Control in Vivo and in Vitro. Endocrinology: 2012; 153 2385 2397
184. Lovshin J., Estall J., Yusta B., Brown T. J., Drucker D. J. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem: 2001; 276 21489 21499
185. Miyawaki K., Yamada Y., Ban N., Ihara Y., Tsukiyama K., Zhou H., Fujimoto S., Oku A., Tsuda K., Toyokuni S. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med: 2002; 8 738 742 (Pubitemid 34778728)
186. Woods S., West D., Stein L. J., McKay L., Lotter E. C., Porte S. G., Kenney N. J., Porte D. Jr. Peptides and the control of meal size. Diabetologia: 1981; 20 305 313 (Pubitemid 11159663)
187. Gault V., McClean P., Cassidy R., Irwin N., Flatt P. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia: 2007; 50 1752 1762 (Pubitemid 47036655)
188. Ambati S., Duan J., Hartzell D. L., Choi Y-H, Della-Fera M. A., Baile C. A. GIP-dependent expression of hypothalamic genes. Physiol Res/Acad Sci Bohem: 2011; 60 941 950
189. Epstein F. H., Strewler G. J. The physiology of parathyroid hormone-related protein. N Engl J Med: 2000; 342 177 185 (Pubitemid 30051650)
190. Asakawa A., Fujimiya M., Niijima A., Fujino K., Kodama N., Sato Y., Kato I., Nanba H., Laviano A., Meguid M. M. Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3. Psychoneuroendocrinology: 2010; 35 1178 1186
191. Burtis W. J., Brady T. G., Orloff J. J., Ersbak J. B., Warrell R. P. Jr, Olson B. R., Wu T. L., Mitnick M. E., Broadus A. E., Stewart A. F. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med: 1990; 322 1106 1112 (Pubitemid 20149527)
192. McCarty M., Thomas C. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis - implications for the impact of calcium, vitamin D, and alcohol on body we ight. Med Hypoth: 2003; 61 535 542 (Pubitemid 37411898)